NCT02320500

Brief Summary

Patients with chronic knee pain attributed to osteoarthritis and referred to orthopedics as potential candidates for a knee replacement will receive standard physiotherapy or myofascial-specific therapy over 8 weeks. Based on the investigators pilot investigation, the investigators expect those who receive myofascial-specific therapy to experience reduced pain (compared to the standard therapy group) and increased flexibility compared to baseline levels. This simple conservative therapy could postpone (or in some cases, eliminate) the need for a knee replacement since pain is the major indication for surgery. If successful, this treatment could improve the quality of life and increase productivity for thousands suffering from knee osteoarthritis and preserve valuable health care resources.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Sep 2013

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

December 2, 2014

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 19, 2014

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

April 6, 2018

Status Verified

April 1, 2018

Enrollment Period

2.8 years

First QC Date

December 2, 2014

Last Update Submit

April 4, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain scores on visual analogue scale (VAS)

    8 weeks

Secondary Outcomes (8)

  • Brief pain inventory (BPI)

    biweekly for 8 weeks, 3 months, 6 months

  • Oxford knee score

    biweekly for 8 weeks, 3 months, 6 months

  • McGill short pain questionnaire

    biweekly for 8 weeks, 3 months, 6 months

  • timed up and go (TUG)

    Baseline, 3 months

  • 6 minute walk test

    Baseline, 3 months

  • +3 more secondary outcomes

Study Arms (2)

standard physiotherapy

ACTIVE COMPARATOR

Standard of care physiotherapy for knee osteoarthritis (OA) patients who have been diagnosed with knee OA and may be candidates for total knee replacement (TKA)

Behavioral: Standard Physiotherapy

Myofascial-specific therapy

EXPERIMENTAL

Patient undergo myofascial pain-specific therapy which includes trigger point injections at the same time points as the comparator (1 session every 2 weeks for 8 weeks)

Other: Myofascial-specific therapy

Interventions

standard of care physiotherapy once every 2 weeks for 8 weeks

standard physiotherapy

Once every 2 weeks for 8 weeks (includes trigger point injections if deemed 'necessary' by chronic pain physician)

Myofascial-specific therapy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of bi or unilateral knee OA
  • knee pain attributed to knee OA
  • referral to orthopedics as a potential candidate for knee total knee arthroplasty
  • ability to comprehend/sign consent, independent mobility without assistive devices

You may not qualify if:

  • allergy/contraindication to study medications (i.e., trigger point injections), previous knee replacement surgery
  • infections of clinical abnormalities other than knee OA that could cause the knee pain
  • other diagnosed chronic pain syndrome for which they are taking regular pain medications
  • pregnancy or breast-feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hotel Dieu Hospital

Kingston, Ontario, Canada

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Richard Henry, MD, FRCPC

    Queens University/Kingston General Hospital

    PRINCIPAL INVESTIGATOR
  • Gavin Wood, MD, FRCSC

    Queens University/Kingston General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 2, 2014

First Posted

December 19, 2014

Study Start

September 1, 2013

Primary Completion

July 1, 2016

Study Completion

December 1, 2016

Last Updated

April 6, 2018

Record last verified: 2018-04

Locations